Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients
Authors
Keywords
Health state utility values (HSUVs), Health-related quality of life (HRQoL), Metastatic non-small cell lung cancer (mNSCLC), Multi-attribute utility instruments (MAUIs), Standard gamble (SG), Time trade-off (TTO), Systematic literature review
Journal
Health and Quality of Life Outcomes
Volume 16, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-12
DOI
10.1186/s12955-018-0994-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Practical Guide to Conducting a Systematic Review and Meta-analysis of Health State Utility Values
- (2018) Stavros Petrou et al. PHARMACOECONOMICS
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Health Related Quality of Life in Cancer Immunotherapy: Previously Treated, Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
- (2017) J Purchase et al. VALUE IN HEALTH
- Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) S. Novello et al. ANNALS OF ONCOLOGY
- Health state utilities in non-small cell lung cancer: An international study
- (2016) Beenish Nafees et al. Asia-Pacific Journal of Clinical Oncology
- Caregivers' accuracy in reporting patients' symptom: A preliminary report.
- (2016) Paola Langer et al. JOURNAL OF CLINICAL ONCOLOGY
- The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial
- (2016) Martin Reck et al. Journal of Thoracic Oncology
- Quality of life, symptom status and physical performance in patients with advanced non-small cell lung cancer undergoing chemotherapy: an exploratory analysis of secondary data
- (2016) Shirin M. Shallwani et al. LUNG CANCER
- Cost-effectiveness analysis of pemetrexed and gemcitabine treatment for advanced nonsmall cell lung cancer in Turkey
- (2016) Pınar YALÇIN BALÇIK et al. Turkish Journal Of Medical Sciences
- A Review of Health State Utility Values Used in UK Nice Appraisals in Advanced NSCLC
- (2016) V Dansk et al. VALUE IN HEALTH
- Measurement of Utilities by Time to Death Related to Advanced Non-Small Cell Lung Cancer in South Korea
- (2016) C Chang et al. VALUE IN HEALTH
- Health state utility values in locally advanced and metastatic breast cancer by treatment line: a systematic review
- (2016) Noman Paracha et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Survival, quality-adjusted survival and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel
- (2015) C J Langer et al. BRITISH JOURNAL OF CANCER
- Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial
- (2015) Domenico Galetta et al. Clinical Lung Cancer
- 3089 Symptom analysis and quality of life (QoL) in patients treated with nivolumab (NIVO) as ≥2nd line therapy for advanced non-small cell lung cancer (aNSCLC)
- (2015) L. Schwartzberg et al. EUROPEAN JOURNAL OF CANCER
- 3011 Evaluation of overall health status in patients with advanced squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 017
- (2015) M. Reck et al. EUROPEAN JOURNAL OF CANCER
- Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer
- (2015) Silvia Novello et al. EUROPEAN JOURNAL OF CANCER
- Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer
- (2015) R. Lal et al. LUNG CANCER
- Health Related Quality Of Life Of Caregivers And Patients Treated For Metastatic Non-Small Cell Lung Cancer (Nsclc) With Oral Vinorelbine
- (2015) H Linnet et al. VALUE IN HEALTH
- KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis
- (2014) Marie Westwood et al. HEALTH TECHNOLOGY ASSESSMENT
- Patient-Reported Outcomes and Quality of Life in PROFILE 1007: A Randomized Trial of Crizotinib Compared with Chemotherapy in Previously Treated Patients with ALK-Positive Advanced Non–Small-Cell Lung Cancer
- (2014) Fiona Blackhall et al. Journal of Thoracic Oncology
- Estimation of loss of quality-adjusted life expectancy (QALE) for patients with operable versus inoperable lung cancer: Adjusting quality-of-life and lead-time bias for utility of surgery
- (2014) Szu-Chun Yang et al. LUNG CANCER
- The continuation rates of long-acting reversible contraceptives in UK general practice using data from The Health Improvement Network
- (2014) Lucía Cea Soriano et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Is progression-free survival associated with a better health-related quality of life in patients with lung cancer? Evidence from two randomised trials with afatinib
- (2014) Ingolf Griebsch et al. BMJ Open
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
- Symptom and Quality of Life Benefit of Afatinib in Advanced Non–Small-Cell Lung Cancer Patients Previously Treated with Erlotinib or Gefitinib: Results of a Randomized Phase IIb/III Trial (LUX-Lung 1)
- (2013) Vera Hirsh et al. Journal of Thoracic Oncology
- Health-Related Quality of Life and Utility in Patients with Advanced Non–Small-Cell Lung Cancer: A Prospective Cross-Sectional Patient Survey in a Real-World Setting
- (2013) Christos Chouaid et al. Journal of Thoracic Oncology
- Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany
- (2013) Shrividya Iyer et al. LUNG CANCER
- A Systematic Review of Utility Values for Chemotherapy-Related Adverse Events
- (2013) Fatiha H. Shabaruddin et al. PHARMACOECONOMICS
- Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer
- (2013) Bradley J. Barney et al. QUALITY OF LIFE RESEARCH
- Systematic Searching and Selection of Health State Utility Values from the Literature
- (2013) Diana Papaioannou et al. VALUE IN HEALTH
- Health State Utility Values in Advanced Non-Small Cell Lung Cancer Patients
- (2013) J. Chevalier et al. VALUE IN HEALTH
- Second-line Treatment of Stage III/IV Non-Small-Cell Lung Cancer (NSCLC) with pemetrexed in routine clinical practice: Evaluation of performance status and health-related quality of life
- (2012) Wolfgang Schuette et al. BMC CANCER
- Interim Data from the Medical Research Council QUARTZ Trial: Does Whole Brain Radiotherapy Affect the Survival and Quality of Life of Patients with Brain Metastases from Non-small Cell Lung Cancer?
- (2012) R.E. Langley et al. CLINICAL ONCOLOGY
- Safety, Resource Use, and Quality of Life in Paramount: A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2012) Cesare Gridelli et al. Journal of Thoracic Oncology
- PCN25 Utility of Advanced Non-Small Cell Lung Cancer Patients in Thailand: Preliminary Study
- (2012) P. Tongpak et al. VALUE IN HEALTH
- Cost Effectiveness of Personalized Therapy for First-Line Treatment of Stage IV and Recurrent Incurable Adenocarcinoma of the Lung
- (2012) Elizabeth A. Handorf et al. Journal of Oncology Practice
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PCN58 A COST UTILITY ANALYSIS OF ERLOTINIB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
- (2011) PA Bradbury et al. VALUE IN HEALTH
- PCN142 EVALUATION OF THE QUALITY OF LIFE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WHO FAILED TO FIRST LINE CHEMOTHERAPY IN TREATMENT WITH ERLOTINIB VS TAXANES
- (2011) J Vargas et al. VALUE IN HEALTH
- PCN94 HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN 1ST LINE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS IN A REAL LIFE SETTING: BEVACIZUMAB-BASED VERSUS NON-BEVACIZUMAB BASED THERAPY IN A EUROPEAN PILOT STUDY
- (2011) C. Chouaid et al. VALUE IN HEALTH
- PMD19 COST-EFFECTIVENESS OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION TESTING IN THE SELECTION OF FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN ONTARIO
- (2011) W. Chen et al. VALUE IN HEALTH
- Health outcomes in economic evaluation: the QALY and utilities
- (2010) S. J. Whitehead et al. BRITISH MEDICAL BULLETIN
- Derivation of Utility Values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 Questionnaire Values in Lung Cancer
- (2010) Raymond W. Jang et al. Journal of Thoracic Oncology
- Significance of the Presence of Microscopic Vascular Invasion After Complete Resection of Stage I–II pT1-T2N0 Non-small Cell Lung Cancer and Its Relation with T-Size Categories: Did the 2009 7th Edition of the TNM Staging System Miss Something?
- (2010) Enrico Ruffini et al. Journal of Thoracic Oncology
- A Review and Meta-Analysis of Utility Values for Lung Cancer
- (2010) Julie Sturza MEDICAL DECISION MAKING
- Importance of Quality of Life in Patients with Non–Small-Cell Lung Cancer
- (2009) Carlos Camps et al. Clinical Lung Cancer
- Improving Health-Related Quality of Life in Non–Small-Cell Lung Cancer with Current Treatment Options
- (2008) David F. Cella et al. Clinical Lung Cancer
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Health state utilities for non small cell lung cancer
- (2008) Beenish Nafees et al. Health and Quality of Life Outcomes
- Health state utility scores in advanced non-small cell lung cancer
- (2008) Scott Doyle et al. LUNG CANCER
- Health State Utility Scores for Cancer-Related Anemia through Societal and Patient Valuations
- (2008) Andrew Lloyd et al. VALUE IN HEALTH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search